Clinical Trials Flashcards

1
Q

Define Superiority Trials

A

Superiority Trials test whether a new drug is better than a comparator (e.g. placebo or current best treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Equivalence Trials

A

Equivalence Trials test whether a new drug is the same as an existing treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define non-inferiority Trials

A

Non-inferiority Trials test whether a new treatment is no worse than an existing treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical equivalence trials

A

Tests whether clinical outcomes for a new drug are the same as for an existing treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bioequivalence trials

A

Tests whether PK parameters e.g. blood concentrations or receptor occupancy for a new drug are the same as for an exisitng treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Compare and contrast Superiority, equivalence and non-inferiority trial designs

A

Superiority:
Most clinical trials
Treatment advance (comparison with placebo or existing best practice)

Equivalence:
Treatment change, comparison with original
(change in drug delivery or manufacture…generic drugs or biosimilars)

Non-Inferiority:
Current effective treatments, where placebo would be unethical
(new treatments may have secondary advantages e.g. better safety, acceptability, cost)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are factors that determine an ‘ideal clinical trial’?

A

The ideal clinical trial determines the safety and efficacy of a new drug

-Clinically meaningful (represents a meaningful advance in healthcare/patient outcomes)
-Reliable (Results can be reproducible if trial is repeated)
-Valid:
Internal: observed differences can be correctly attributed to the intervention
External: trial results can be generalised to the real-world population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

State the null and alternative hypothesis for superiority trials

A

Null hypothesis: Treatment is not better than or the same as the comparator
Alternative hypothesis: Treatment is better than comparator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State the null and alternative hypothesis for Equivalence trials

A

Null hypothesis: Treatment is not similar to comparator
Alternative hypothesis: Treatment is similar to comparator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

State the null and alternative hypothesis for non-inferiority trials

A

Null hypothesis: Treatment is worse than comparator
Alternative hypothesis: Treatment is not worse than (is the same or better than comparator)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a one-sided test?

A

Tests for the possibility of a relationship in one direction.
One-sided tests provides more power to detect an effect.
Risk of missing an effect in the other direction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a two-sided test

A

Tests for the possibility of a relationship in both directions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define Bias

A

Systematic distortion of the results of a clinical study away from the truth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List some causes of bias in clinical trials

A

Caused by inadequacies in design, conduct or analysis of the trial or
publication of its results

Reduces validity of study results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Per protocol analysis

A

Determines maximum potential effectiveness of treatment

Don’t have to worry about drop outs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intention to treat

A

Preserves randomisation
* Minimises bias
* Deals with dropouts
* Mirrors real life
* Allows interim analysis
* Practical and pragmatic
* Might miss a real effect

17
Q

Define confounders

A

A parameter that is related to both the study treatment and the outcome, but is not caused by the treatment. Confounders can interfere with the ability of a trial to produce a true result and should be controlled for in study design by randomisation

18
Q

How can confounders be minimised?

A

Randomisation

Stratification

Minimisation

19
Q

Define randomisation

A

A process of allocating participants to study groups that gives everyone an equal chance of being allocated to any group

20
Q

Define stratification

A

Randomisation within subgroups of key confounders

21
Q

Define minimisation

A

Dynamic method of randomisation that assigns participants to treatment groups in an order that minimises overall imbalance between groups for a number of selected confounding factors

22
Q

Define Type 1 error

A

Rejecting the null hypothesis when it is true, false positive result

Designated as alpha, usually set at 0.05 (5%)

23
Q

Define Type 2 error

A

Failing to reject the null hypothesis when it is false, false negative result

Designated as beta, usually set at 20%

24
Q

How is the risk of random error reduced?

A

Reduced by large sample
and less variance

25
Define power (of a study)
The ability of a study to find a significant result if one exists Calculated as 100-beta (if beta is 20%, power is 80%)
26
Define multiplicity
Performing many statistical tests on one clinical trial - increases the risk of a type 1 error/false positive result
27
What is the risk of type 1 error?
[1-(1-alpha)n], where n is the number of tests performed and alpha is the type 1 error rate
28
Define minimisation
Dynamic method of randomisation that assigns participants to treatment groups in an order that minimises overall imbalance between groups for a number of selected confounding factors
29
Define stratification
Randomisation within subgroups of key confounders
30
What is an interim analysis
Analysis conducted during the trial for ethical or economic reasons - trial may be terminated early if significant differences in efficacy or safety are identified
31
Define Bonferroni correction
Reducing the alpha of statistical tests to reduce the risk of a false positive result - divide 0.05 by the number of tests to set the significance level for the subtests
32
Define covariate
Baseline characteristic (e.g. age, sex) that accounts for some of the variance in an outcome measured in a clinical trial (e.g. age is associated with increased risk of mortality). May modify the effect of a new treatment (e.g. drug may work in younger but not older patients)